Biomarin Pharmaceutical Inc (BMRN)
Financial leverage ratio
| Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | US$ in thousands | 7,614,870 | 7,456,340 | 7,147,010 | 6,988,940 | 6,851,200 | 7,067,120 | 6,872,670 | 6,841,600 | 6,758,160 | 6,563,170 | 6,433,700 | 6,375,070 | 6,264,040 | 6,145,840 | 6,062,710 | 6,003,320 | 5,977,480 | 5,898,500 | 5,805,050 | 5,848,020 |
| Total stockholders’ equity | US$ in thousands | 6,056,710 | 6,027,110 | 5,793,460 | 5,657,990 | 5,413,400 | 5,286,300 | 5,073,820 | 4,951,550 | 4,896,900 | 4,782,830 | 4,659,040 | 4,603,160 | 4,568,510 | 4,504,810 | 4,391,320 | 4,270,740 | 4,266,150 | 4,241,570 | 4,162,010 | 4,106,000 |
| Financial leverage ratio | 1.26 | 1.24 | 1.23 | 1.24 | 1.27 | 1.34 | 1.35 | 1.38 | 1.38 | 1.37 | 1.38 | 1.38 | 1.37 | 1.36 | 1.38 | 1.41 | 1.40 | 1.39 | 1.39 | 1.42 |
September 30, 2025 calculation
Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $7,614,870K ÷ $6,056,710K
= 1.26
Peer comparison
Sep 30, 2025
Company name
Symbol
Financial leverage ratio
Biomarin Pharmaceutical Inc
BMRN
1.26
Arrowhead Pharmaceuticals Inc
ARWR
2.97
Regeneron Pharmaceuticals Inc
REGN
1.30